

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.10521660 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.71440980 |
| 3 | complement activation, alternative pathway (GO:0006957) | 8.37584008 |
| 4 | regulation of protein activation cascade (GO:2000257) | 8.13682051 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.97524649 |
| 6 | lysine metabolic process (GO:0006553) | 7.75399794 |
| 7 | lysine catabolic process (GO:0006554) | 7.75399794 |
| 8 | regulation of complement activation (GO:0030449) | 7.64897309 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 7.46800813 |
| 10 | drug transmembrane transport (GO:0006855) | 7.29482072 |
| 11 | urate metabolic process (GO:0046415) | 7.11802279 |
| 12 | cysteine metabolic process (GO:0006534) | 6.73164112 |
| 13 | glyoxylate metabolic process (GO:0046487) | 6.61430693 |
| 14 | drug transport (GO:0015893) | 6.36111358 |
| 15 | fibrinolysis (GO:0042730) | 6.32875724 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.29401737 |
| 17 | protein carboxylation (GO:0018214) | 6.29401737 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 6.18441310 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 6.17169942 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 6.14765112 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.14765112 |
| 22 | blood coagulation, intrinsic pathway (GO:0007597) | 6.09642314 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 6.08766986 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08766986 |
| 25 | tryptophan catabolic process (GO:0006569) | 6.02638662 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 6.02638662 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 6.02638662 |
| 28 | organic cation transport (GO:0015695) | 5.89295721 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 5.76044829 |
| 30 | oxidative demethylation (GO:0070989) | 5.75760771 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 5.73172689 |
| 32 | tryptophan metabolic process (GO:0006568) | 5.64845334 |
| 33 | kynurenine metabolic process (GO:0070189) | 5.57401659 |
| 34 | ethanol metabolic process (GO:0006067) | 5.51596614 |
| 35 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.48601451 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.46291581 |
| 37 | phosphate ion transport (GO:0006817) | 5.42794221 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 5.38103366 |
| 39 | protein activation cascade (GO:0072376) | 5.33042037 |
| 40 | glycine metabolic process (GO:0006544) | 5.31769078 |
| 41 | response to mercury ion (GO:0046689) | 5.29133243 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 5.25910766 |
| 43 | sulfur amino acid catabolic process (GO:0000098) | 5.23772521 |
| 44 | regulation of plasminogen activation (GO:0010755) | 5.22251896 |
| 45 | complement activation (GO:0006956) | 5.17030573 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 5.13877054 |
| 47 | homocysteine metabolic process (GO:0050667) | 5.12686365 |
| 48 | quaternary ammonium group transport (GO:0015697) | 5.07987353 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07611718 |
| 50 | drug catabolic process (GO:0042737) | 5.06139212 |
| 51 | acute-phase response (GO:0006953) | 5.05238390 |
| 52 | complement activation, classical pathway (GO:0006958) | 5.03250792 |
| 53 | ketone body metabolic process (GO:1902224) | 4.98291534 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 4.96798490 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.92819352 |
| 56 | phosphate ion transmembrane transport (GO:0035435) | 4.91567975 |
| 57 | regulation of humoral immune response (GO:0002920) | 4.88336805 |
| 58 | opsonization (GO:0008228) | 4.86066909 |
| 59 | negative regulation of protein activation cascade (GO:2000258) | 4.77284788 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 4.75539855 |
| 61 | negative regulation of hemostasis (GO:1900047) | 4.75539855 |
| 62 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72827773 |
| 63 | glutamate metabolic process (GO:0006536) | 4.70044927 |
| 64 | S-adenosylmethionine metabolic process (GO:0046500) | 4.66989271 |
| 65 | acylglycerol homeostasis (GO:0055090) | 4.66109381 |
| 66 | triglyceride homeostasis (GO:0070328) | 4.66109381 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.61002702 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.56457585 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.54864962 |
| 70 | aromatic amino acid family metabolic process (GO:0009072) | 4.52662914 |
| 71 | tricarboxylic acid metabolic process (GO:0072350) | 4.52527755 |
| 72 | valine metabolic process (GO:0006573) | 4.51181085 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 4.48407352 |
| 74 | flavonoid metabolic process (GO:0009812) | 4.45733185 |
| 75 | branched-chain amino acid metabolic process (GO:0009081) | 4.40810887 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.40223755 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.40223755 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.37891155 |
| 79 | cytolysis (GO:0019835) | 4.35605333 |
| 80 | negative regulation of wound healing (GO:0061045) | 4.35104328 |
| 81 | excretion (GO:0007588) | 4.33630702 |
| 82 | negative regulation of coagulation (GO:0050819) | 4.31696631 |
| 83 | fatty acid beta-oxidation (GO:0006635) | 4.30939414 |
| 84 | amino-acid betaine transport (GO:0015838) | 4.30241924 |
| 85 | carnitine transport (GO:0015879) | 4.30241924 |
| 86 | alpha-amino acid catabolic process (GO:1901606) | 4.29852600 |
| 87 | carnitine metabolic process (GO:0009437) | 4.28375723 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 4.28138950 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 4.26117838 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 4.22189737 |
| 91 | exogenous drug catabolic process (GO:0042738) | 4.21312876 |
| 92 | hormone catabolic process (GO:0042447) | 4.21015748 |
| 93 | vitamin D metabolic process (GO:0042359) | 4.17799922 |
| 94 | phospholipid efflux (GO:0033700) | 4.17420290 |
| 95 | cellular glucuronidation (GO:0052695) | 4.14790260 |
| 96 | arginine metabolic process (GO:0006525) | 4.13636819 |
| 97 | alkaloid metabolic process (GO:0009820) | 4.13206005 |
| 98 | fructose metabolic process (GO:0006000) | 4.12904669 |
| 99 | bile acid biosynthetic process (GO:0006699) | 4.11825074 |
| 100 | plasma lipoprotein particle remodeling (GO:0034369) | 4.10973282 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 4.10973282 |
| 102 | macromolecular complex remodeling (GO:0034367) | 4.10973282 |
| 103 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.09858230 |
| 104 | negative regulation of complement activation (GO:0045916) | 4.09646664 |
| 105 | glucuronate metabolic process (GO:0019585) | 4.01787138 |
| 106 | uronic acid metabolic process (GO:0006063) | 4.01787138 |
| 107 | glucocorticoid biosynthetic process (GO:0006704) | 3.99038515 |
| 108 | alpha-linolenic acid metabolic process (GO:0036109) | 3.99021360 |
| 109 | amine catabolic process (GO:0009310) | 3.99014016 |
| 110 | cellular biogenic amine catabolic process (GO:0042402) | 3.99014016 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 3.95777006 |
| 112 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.95630239 |
| 113 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.95630239 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.93819455 |
| 115 | * fatty acid oxidation (GO:0019395) | 3.93291815 |
| 116 | cholesterol efflux (GO:0033344) | 3.92909125 |
| 117 | renal absorption (GO:0070293) | 3.88230252 |
| 118 | positive regulation of hemostasis (GO:1900048) | 3.87691067 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 3.87691067 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 3.86337343 |
| 121 | organic acid catabolic process (GO:0016054) | 3.86337343 |
| 122 | * lipid oxidation (GO:0034440) | 3.85559997 |
| 123 | negative regulation of lipase activity (GO:0060192) | 3.84285391 |
| 124 | response to phenylpropanoid (GO:0080184) | 3.82757134 |
| 125 | glutathione biosynthetic process (GO:0006750) | 3.82707769 |
| 126 | acute inflammatory response (GO:0002526) | 3.80116361 |
| 127 | high-density lipoprotein particle remodeling (GO:0034375) | 3.78049494 |
| 128 | monocarboxylic acid catabolic process (GO:0072329) | 3.76286033 |
| 129 | negative regulation of sterol transport (GO:0032372) | 3.76088420 |
| 130 | negative regulation of cholesterol transport (GO:0032375) | 3.76088420 |
| 131 | fatty acid catabolic process (GO:0009062) | 3.75917314 |
| 132 | regulation of cholesterol esterification (GO:0010872) | 3.74701674 |
| 133 | drug metabolic process (GO:0017144) | 3.71305451 |
| 134 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.66166820 |
| 135 | xenobiotic metabolic process (GO:0006805) | 3.66061441 |
| 136 | bile acid metabolic process (GO:0008206) | 3.65639354 |
| 137 | aldehyde catabolic process (GO:0046185) | 3.62797147 |
| 138 | proline metabolic process (GO:0006560) | 3.62605751 |
| 139 | steroid catabolic process (GO:0006706) | 3.62360309 |
| 140 | dicarboxylic acid metabolic process (GO:0043648) | 3.61330091 |
| 141 | positive regulation of coagulation (GO:0050820) | 3.57097322 |
| 142 | indole-containing compound metabolic process (GO:0042430) | 3.55837282 |
| 143 | ethanol oxidation (GO:0006069) | 3.53700436 |
| 144 | tyrosine metabolic process (GO:0006570) | 3.53389735 |
| 145 | reverse cholesterol transport (GO:0043691) | 3.52495203 |
| 146 | metanephric tubule development (GO:0072170) | 3.49375481 |
| 147 | metanephric nephron tubule development (GO:0072234) | 3.49375481 |
| 148 | regulation of acute inflammatory response (GO:0002673) | 3.47458246 |
| 149 | modified amino acid transport (GO:0072337) | 3.46899163 |
| 150 | positive regulation of lipid catabolic process (GO:0050996) | 3.46811853 |
| 151 | biotin metabolic process (GO:0006768) | 3.46583052 |
| 152 | response to growth hormone (GO:0060416) | 3.45160099 |
| 153 | heme transport (GO:0015886) | 3.42589871 |
| 154 | regulation of cholesterol homeostasis (GO:2000188) | 3.39900203 |
| 155 | vitamin transport (GO:0051180) | 3.37019073 |
| 156 | small molecule catabolic process (GO:0044282) | 3.35969304 |
| 157 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.35512245 |
| 158 | glutathione derivative metabolic process (GO:1901685) | 3.26105868 |
| 159 | glutathione derivative biosynthetic process (GO:1901687) | 3.26105868 |
| 160 | glutathione metabolic process (GO:0006749) | 3.25822958 |
| 161 | urea metabolic process (GO:0019627) | 3.20844193 |
| 162 | urea cycle (GO:0000050) | 3.20844193 |
| 163 | L-ascorbic acid metabolic process (GO:0019852) | 3.20718143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.28398710 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.03666514 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.98673610 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.63236814 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.44512830 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.17088345 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.57552211 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.05691397 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.95866724 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.75222437 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.64025628 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.63370618 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43963245 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23486973 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99170372 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96879265 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95030759 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.93642243 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.92065363 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91971913 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88479050 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83713328 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68464379 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63559956 |
| 25 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.57229378 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56089529 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51951014 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.50816622 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50572340 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49840784 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46900432 |
| 32 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44983270 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42416330 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34250620 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28538302 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23204589 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21919332 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18417315 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18214815 |
| 40 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16252551 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12511926 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08569474 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07776743 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06301036 |
| 45 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.05222706 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05137683 |
| 47 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00605566 |
| 48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00503744 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98902031 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97611202 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97506792 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96723367 |
| 53 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.95552720 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94127788 |
| 55 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93727340 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93450791 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91620363 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90877076 |
| 59 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90552661 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90032312 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.89307228 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88698358 |
| 63 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87540723 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85922688 |
| 65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85874557 |
| 66 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85428186 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84980898 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84836621 |
| 69 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.83661727 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82295247 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82262574 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81280502 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78494303 |
| 74 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.77605810 |
| 75 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76918761 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76464148 |
| 77 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.75937082 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75835164 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74290312 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74056591 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73105309 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72540138 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71927533 |
| 84 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.71552840 |
| 85 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.71001852 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70931907 |
| 87 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70822343 |
| 88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70181808 |
| 89 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70181808 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70136582 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69141963 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68794530 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68794530 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68400396 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67371091 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67034143 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.66526113 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65877347 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65769973 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65659169 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65556193 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.65273368 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.64828891 |
| 104 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64794847 |
| 105 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.64695320 |
| 106 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.63882625 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.63494584 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.62467053 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62419505 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62318107 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62261490 |
| 112 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62081066 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.61991509 |
| 114 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.61899733 |
| 115 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61889731 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61525380 |
| 117 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61171395 |
| 118 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.61135831 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.60800922 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60068663 |
| 121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.59465334 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59389361 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59241121 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58993296 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58568358 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58493368 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58353641 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.58011645 |
| 129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.57757576 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.57323639 |
| 131 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57223331 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56673494 |
| 133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56567413 |
| 134 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.56567230 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56193986 |
| 136 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.55977962 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.55753224 |
| 138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55371029 |
| 139 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55218011 |
| 140 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.55135844 |
| 141 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.54395568 |
| 142 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.54314835 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.54246517 |
| 144 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.53851180 |
| 145 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52821211 |
| 146 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.52748785 |
| 147 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.52601371 |
| 148 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.51337529 |
| 149 | SA1_27219007_Chip-Seq_Bcells_Human | 0.50760919 |
| 150 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.50611979 |
| 151 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.50375473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.45451237 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.50982798 |
| 3 | MP0005332_abnormal_amino_acid | 4.32158894 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.30990679 |
| 5 | MP0004043_abnormal_pH_regulation | 4.30498324 |
| 6 | MP0005365_abnormal_bile_salt | 4.18756266 |
| 7 | MP0003195_calcinosis | 4.15177268 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 4.02823671 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.99079461 |
| 10 | MP0009643_abnormal_urine_homeostasis | 3.21584711 |
| 11 | MP0009697_abnormal_copulation | 3.10631529 |
| 12 | MP0003252_abnormal_bile_duct | 3.08645943 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 3.01486164 |
| 14 | MP0001765_abnormal_ion_homeostasis | 2.74933869 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.68612028 |
| 16 | MP0005636_abnormal_mineral_homeostasis | 2.61843768 |
| 17 | MP0001756_abnormal_urination | 2.55703168 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.15014936 |
| 19 | MP0002136_abnormal_kidney_physiology | 2.11650976 |
| 20 | MP0003878_abnormal_ear_physiology | 2.02260922 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 2.02260922 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.95611289 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.88100713 |
| 24 | MP0005451_abnormal_body_composition | 1.82716141 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.75489129 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.70294715 |
| 27 | MP0003186_abnormal_redox_activity | 1.61376985 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.60711671 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.55151161 |
| 30 | MP0009840_abnormal_foam_cell | 1.47671006 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.45405652 |
| 32 | MP0005083_abnormal_biliary_tract | 1.41345622 |
| 33 | MP0000609_abnormal_liver_physiology | 1.34525997 |
| 34 | MP0001764_abnormal_homeostasis | 1.33612918 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.30677540 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.28092293 |
| 37 | MP0001958_emphysema | 1.28037033 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.26403461 |
| 39 | MP0002132_abnormal_respiratory_system | 1.18507214 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.18106934 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.12215619 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.10531171 |
| 43 | MP0003283_abnormal_digestive_organ | 1.02957404 |
| 44 | MP0004264_abnormal_extraembryonic_tissu | 1.02397559 |
| 45 | MP0001661_extended_life_span | 0.99906148 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.99228030 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 0.92667202 |
| 48 | MP0003868_abnormal_feces_composition | 0.92203473 |
| 49 | MP0002168_other_aberrant_phenotype | 0.90354356 |
| 50 | MP0005535_abnormal_body_temperature | 0.90072853 |
| 51 | MP0009642_abnormal_blood_homeostasis | 0.89783884 |
| 52 | MP0004885_abnormal_endolymph | 0.88707446 |
| 53 | MP0005187_abnormal_penis_morphology | 0.87809236 |
| 54 | MP0003638_abnormal_response/metabolism_ | 0.87246427 |
| 55 | MP0002928_abnormal_bile_duct | 0.87167967 |
| 56 | MP0001915_intracranial_hemorrhage | 0.82300974 |
| 57 | MP0002135_abnormal_kidney_morphology | 0.81902866 |
| 58 | MP0009764_decreased_sensitivity_to | 0.80638095 |
| 59 | MP0005670_abnormal_white_adipose | 0.79852948 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 0.76946879 |
| 61 | MP0000598_abnormal_liver_morphology | 0.76883738 |
| 62 | MP0003011_delayed_dark_adaptation | 0.74176619 |
| 63 | MP0008469_abnormal_protein_level | 0.72155322 |
| 64 | MP0002282_abnormal_trachea_morphology | 0.71142311 |
| 65 | MP0005666_abnormal_adipose_tissue | 0.70675413 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.65704878 |
| 67 | MP0005395_other_phenotype | 0.65178155 |
| 68 | MP0002896_abnormal_bone_mineralization | 0.64608088 |
| 69 | MP0000604_amyloidosis | 0.62094473 |
| 70 | MP0005647_abnormal_sex_gland | 0.61276082 |
| 71 | MP0008874_decreased_physiological_sensi | 0.60161149 |
| 72 | MP0002796_impaired_skin_barrier | 0.59549767 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.59119992 |
| 74 | MP0003953_abnormal_hormone_level | 0.57013960 |
| 75 | MP0005408_hypopigmentation | 0.56952768 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.56587450 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.56146166 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.55218582 |
| 79 | MP0003329_amyloid_beta_deposits | 0.54174291 |
| 80 | MP0005464_abnormal_platelet_physiology | 0.53645358 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.52072221 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.50794021 |
| 83 | MP0003959_abnormal_lean_body | 0.50267054 |
| 84 | MP0009785_altered_susceptibility_to | 0.49436611 |
| 85 | MP0001663_abnormal_digestive_system | 0.49362287 |
| 86 | MP0004130_abnormal_muscle_cell | 0.49006304 |
| 87 | MP0004147_increased_porphyrin_level | 0.45831424 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.44505851 |
| 89 | MP0003879_abnormal_hair_cell | 0.43406913 |
| 90 | MP0000249_abnormal_blood_vessel | 0.42890975 |
| 91 | MP0003075_altered_response_to | 0.42665792 |
| 92 | MP0005023_abnormal_wound_healing | 0.41781841 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.41076244 |
| 94 | MP0005266_abnormal_metabolism | 0.41018174 |
| 95 | MP0002971_abnormal_brown_adipose | 0.40459623 |
| 96 | MP0003646_muscle_fatigue | 0.40002051 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.39855699 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.38252370 |
| 99 | MP0009763_increased_sensitivity_to | 0.38130685 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.37147327 |
| 101 | MP0005334_abnormal_fat_pad | 0.36831035 |
| 102 | MP0002090_abnormal_vision | 0.34577594 |
| 103 | MP0003724_increased_susceptibility_to | 0.34409726 |
| 104 | MP0003690_abnormal_glial_cell | 0.34184930 |
| 105 | MP0009053_abnormal_anal_canal | 0.33451364 |
| 106 | MP0005166_decreased_susceptibility_to | 0.33195505 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.33116633 |
| 108 | MP0003315_abnormal_perineum_morphology | 0.32191351 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.31658947 |
| 110 | MP0002822_catalepsy | 0.31487035 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.30982653 |
| 112 | MP0008872_abnormal_physiological_respon | 0.30795462 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.30119739 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.29614085 |
| 115 | MP0005501_abnormal_skin_physiology | 0.28836541 |
| 116 | MP0010155_abnormal_intestine_physiology | 0.27810465 |
| 117 | MP0005448_abnormal_energy_balance | 0.27762471 |
| 118 | MP0005164_abnormal_response_to | 0.26787170 |
| 119 | MP0001664_abnormal_digestion | 0.26684683 |
| 120 | MP0004883_abnormal_blood_vessel | 0.25856684 |
| 121 | MP0009115_abnormal_fat_cell | 0.25079342 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.22209216 |
| 123 | MP0003718_maternal_effect | 0.19316241 |
| 124 | MP0008873_increased_physiological_sensi | 0.18838011 |
| 125 | MP0001851_eye_inflammation | 0.17582200 |
| 126 | MP0009672_abnormal_birth_weight | 0.17569417 |
| 127 | MP0005197_abnormal_uvea_morphology | 0.17118720 |
| 128 | MP0002970_abnormal_white_adipose | 0.17054387 |
| 129 | MP0000566_synostosis | 0.15775266 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.14900737 |
| 131 | MP0004272_abnormal_basement_membrane | 0.14789710 |
| 132 | MP0002128_abnormal_blood_circulation | 0.14571172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of complement system (HP:0005339) | 8.13550772 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.68218589 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.65515185 |
| 4 | Increased circulating renin level (HP:0000848) | 6.28603477 |
| 5 | Gout (HP:0001997) | 5.97380839 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.91993748 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 5.88667637 |
| 8 | Hypokalemic alkalosis (HP:0001949) | 5.77283084 |
| 9 | Hypomagnesemia (HP:0002917) | 5.51627083 |
| 10 | Hyperglycinuria (HP:0003108) | 5.35092728 |
| 11 | Glomerulonephritis (HP:0000099) | 5.22727806 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.21455867 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16425575 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.09394699 |
| 15 | Abnormality of chloride homeostasis (HP:0011422) | 5.08545280 |
| 16 | Polyuria (HP:0000103) | 5.08078201 |
| 17 | Abnormal urine output (HP:0012590) | 4.94954847 |
| 18 | Alkalosis (HP:0001948) | 4.73879870 |
| 19 | Proximal tubulopathy (HP:0000114) | 4.73800547 |
| 20 | Abnormality of magnesium homeostasis (HP:0004921) | 4.71338757 |
| 21 | Hyperuricemia (HP:0002149) | 4.64786394 |
| 22 | Increased purine levels (HP:0004368) | 4.64786394 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.58516840 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.58516840 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.58200823 |
| 26 | Abnormality of renal excretion (HP:0011036) | 4.57679286 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 4.55755003 |
| 28 | Hypolipoproteinemia (HP:0010981) | 4.46014044 |
| 29 | Renal salt wasting (HP:0000127) | 4.33956808 |
| 30 | Hyperaldosteronism (HP:0000859) | 4.26616933 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 4.26067822 |
| 32 | Spontaneous abortion (HP:0005268) | 4.19862966 |
| 33 | Abnormal drinking behavior (HP:0030082) | 4.11047902 |
| 34 | Polydipsia (HP:0001959) | 4.11047902 |
| 35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.10683442 |
| 36 | Ketoacidosis (HP:0001993) | 4.10630131 |
| 37 | Ketosis (HP:0001946) | 4.05286428 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 4.01939743 |
| 39 | Tetany (HP:0001281) | 3.97145608 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83550584 |
| 41 | Nephritis (HP:0000123) | 3.77815282 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.74429590 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.63430760 |
| 44 | Generalized aminoaciduria (HP:0002909) | 3.61559018 |
| 45 | Hyperglycinemia (HP:0002154) | 3.61444256 |
| 46 | Hyperammonemia (HP:0001987) | 3.53944684 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.41500891 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.36652030 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 3.34727456 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.22729121 |
| 51 | Abnormality of urine glucose concentration (HP:0011016) | 3.22588455 |
| 52 | Glycosuria (HP:0003076) | 3.22588455 |
| 53 | Hypokalemia (HP:0002900) | 3.21826955 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 3.17030309 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.17030309 |
| 56 | Hydroxyprolinuria (HP:0003080) | 3.13121060 |
| 57 | Abnormality of proline metabolism (HP:0010907) | 3.13121060 |
| 58 | Renal tubular acidosis (HP:0001947) | 3.12581322 |
| 59 | Xanthomatosis (HP:0000991) | 3.11399960 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01852177 |
| 61 | Intrahepatic cholestasis (HP:0001406) | 2.97846242 |
| 62 | Hypercalciuria (HP:0002150) | 2.95630691 |
| 63 | Vascular calcification (HP:0004934) | 2.92848036 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.89719572 |
| 65 | Gingival bleeding (HP:0000225) | 2.87426479 |
| 66 | Metabolic acidosis (HP:0001942) | 2.86427118 |
| 67 | Osteomalacia (HP:0002749) | 2.76162274 |
| 68 | Hypoglycemic coma (HP:0001325) | 2.72042763 |
| 69 | Hyperphosphaturia (HP:0003109) | 2.71119903 |
| 70 | Abnormality of potassium homeostasis (HP:0011042) | 2.69813364 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.69546264 |
| 72 | Hypercholesterolemia (HP:0003124) | 2.69215028 |
| 73 | Malnutrition (HP:0004395) | 2.67409043 |
| 74 | Vomiting (HP:0002013) | 2.63803414 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.60580544 |
| 76 | Neonatal hypoglycemia (HP:0001998) | 2.59178273 |
| 77 | Nephrolithiasis (HP:0000787) | 2.57902113 |
| 78 | Epidermoid cyst (HP:0200040) | 2.56956542 |
| 79 | Thrombophlebitis (HP:0004418) | 2.55595190 |
| 80 | Lethargy (HP:0001254) | 2.53765303 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.51410657 |
| 82 | Purpura (HP:0000979) | 2.48941995 |
| 83 | Abnormal urine phosphate concentration (HP:0012599) | 2.47180942 |
| 84 | Rickets (HP:0002748) | 2.45334460 |
| 85 | Pulmonary embolism (HP:0002204) | 2.44986197 |
| 86 | Abnormal tarsal ossification (HP:0008369) | 2.37593525 |
| 87 | Mitral stenosis (HP:0001718) | 2.35650704 |
| 88 | Hypophosphatemia (HP:0002148) | 2.35552218 |
| 89 | Nephrocalcinosis (HP:0000121) | 2.32400551 |
| 90 | Steatorrhea (HP:0002570) | 2.31356136 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.30145605 |
| 92 | Enlarged kidneys (HP:0000105) | 2.29590610 |
| 93 | Dehydration (HP:0001944) | 2.28245291 |
| 94 | Menorrhagia (HP:0000132) | 2.27634046 |
| 95 | Neonatal onset (HP:0003623) | 2.27021104 |
| 96 | Fair hair (HP:0002286) | 2.26084740 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.18809241 |
| 98 | Cholecystitis (HP:0001082) | 2.18809241 |
| 99 | Irritability (HP:0000737) | 2.15920561 |
| 100 | Confusion (HP:0001289) | 2.15605228 |
| 101 | Methylmalonic aciduria (HP:0012120) | 2.14842983 |
| 102 | Abnormality of serum amino acid levels (HP:0003112) | 2.14072284 |
| 103 | Widely patent fontanelles and sutures (HP:0004492) | 2.13974682 |
| 104 | Abnormality of sodium homeostasis (HP:0010931) | 2.10203767 |
| 105 | Delayed epiphyseal ossification (HP:0002663) | 2.09279994 |
| 106 | Vacuolated lymphocytes (HP:0001922) | 2.08122012 |
| 107 | Cholelithiasis (HP:0001081) | 2.07923821 |
| 108 | Joint hemorrhage (HP:0005261) | 2.07512191 |
| 109 | Nausea (HP:0002018) | 2.07033943 |
| 110 | Hypobetalipoproteinemia (HP:0003563) | 2.06317640 |
| 111 | Hyponatremia (HP:0002902) | 2.05185721 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 2.03107110 |
| 113 | Arthropathy (HP:0003040) | 2.03002674 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01866869 |
| 115 | Complement deficiency (HP:0004431) | 10.1108922 |
| 116 | Gangrene (HP:0100758) | 1.97313114 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.96438648 |
| 118 | Renal tubular dysfunction (HP:0000124) | 1.94836945 |
| 119 | Cerebral edema (HP:0002181) | 1.94513720 |
| 120 | Hepatocellular carcinoma (HP:0001402) | 1.93919398 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.93675895 |
| 122 | Adrenal overactivity (HP:0002717) | 1.91901371 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 1.90919378 |
| 124 | Hyperlipoproteinemia (HP:0010980) | 1.90652596 |
| 125 | Potter facies (HP:0002009) | 1.90169494 |
| 126 | Facial shape deformation (HP:0011334) | 1.90169494 |
| 127 | Increased serum ferritin (HP:0003281) | 1.89934274 |
| 128 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89482213 |
| 129 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88900758 |
| 130 | Fat malabsorption (HP:0002630) | 1.83941853 |
| 131 | Late onset (HP:0003584) | 1.83740287 |
| 132 | Chondrocalcinosis (HP:0000934) | 1.83338806 |
| 133 | Prolonged partial thromboplastin time (HP:0003645) | 1.80489882 |
| 134 | Sensorimotor neuropathy (HP:0007141) | 1.80439726 |
| 135 | Abnormality of vitamin metabolism (HP:0100508) | 1.77994459 |
| 136 | Spastic diplegia (HP:0001264) | 1.75928171 |
| 137 | Atrioventricular block (HP:0001678) | 1.74723368 |
| 138 | Abnormality of methionine metabolism (HP:0010901) | 1.74605728 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73947804 |
| 140 | Hyperbilirubinemia (HP:0002904) | 1.73941943 |
| 141 | Myocardial infarction (HP:0001658) | 1.73583161 |
| 142 | Abnormality of carpal bone ossification (HP:0006257) | 1.72605737 |
| 143 | Poikilocytosis (HP:0004447) | 1.70725540 |
| 144 | Joint swelling (HP:0001386) | 1.69106546 |
| 145 | Impaired platelet aggregation (HP:0003540) | 1.68246345 |
| 146 | Abnormal platelet function (HP:0011869) | 1.68246345 |
| 147 | Hypophosphatemic rickets (HP:0004912) | 1.64838316 |
| 148 | Increased mean platelet volume (HP:0011877) | 1.63372804 |
| 149 | Cerebral palsy (HP:0100021) | 1.63352055 |
| 150 | Pancreatitis (HP:0001733) | 1.62572922 |
| 151 | Epistaxis (HP:0000421) | 1.60627854 |
| 152 | Abnormal biliary tract physiology (HP:0012439) | 1.56182129 |
| 153 | Bile duct proliferation (HP:0001408) | 1.56182129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.25382018 |
| 2 | WNK4 | 6.99157057 |
| 3 | OXSR1 | 6.50173639 |
| 4 | BCKDK | 4.40610906 |
| 5 | STK39 | 3.03910449 |
| 6 | PRPF4B | 2.44664950 |
| 7 | STK38L | 2.40682910 |
| 8 | MST1R | 2.20768591 |
| 9 | FGFR4 | 1.87539513 |
| 10 | MAP3K7 | 1.79589158 |
| 11 | ERN1 | 1.73653890 |
| 12 | PDK3 | 1.71739077 |
| 13 | PDK4 | 1.71739077 |
| 14 | NEK1 | 1.68835292 |
| 15 | SGK494 | 1.67530981 |
| 16 | SGK223 | 1.67530981 |
| 17 | EPHA3 | 1.65917578 |
| 18 | PRKCG | 1.53967319 |
| 19 | TNK2 | 1.36883162 |
| 20 | SIK1 | 1.36103928 |
| 21 | NTRK3 | 1.35647006 |
| 22 | PDK2 | 1.34058795 |
| 23 | IGF1R | 1.24281883 |
| 24 | WNK1 | 1.23411658 |
| 25 | FRK | 1.19862646 |
| 26 | JAK1 | 1.13505057 |
| 27 | FGFR3 | 1.05891440 |
| 28 | PTK6 | 1.05652214 |
| 29 | PINK1 | 1.04441749 |
| 30 | STK38 | 1.04414751 |
| 31 | TRIB3 | 1.02948779 |
| 32 | MST4 | 1.02081294 |
| 33 | INSRR | 0.97562640 |
| 34 | NLK | 0.97492125 |
| 35 | ARAF | 0.96582747 |
| 36 | SGK3 | 0.95140148 |
| 37 | GRK6 | 0.94821043 |
| 38 | PRKG1 | 0.92402995 |
| 39 | SGK2 | 0.91660315 |
| 40 | MAP3K6 | 0.89120268 |
| 41 | TAOK2 | 0.86918352 |
| 42 | TIE1 | 0.85834566 |
| 43 | LRRK2 | 0.85387256 |
| 44 | PRKAA2 | 0.85005607 |
| 45 | EPHB1 | 0.81727871 |
| 46 | DYRK1B | 0.79844767 |
| 47 | PKN2 | 0.79468553 |
| 48 | MAP3K12 | 0.79272782 |
| 49 | ABL2 | 0.79009142 |
| 50 | GSK3A | 0.77556741 |
| 51 | PRKAA1 | 0.77277477 |
| 52 | MAPK7 | 0.76401142 |
| 53 | MAP3K1 | 0.74596918 |
| 54 | CSF1R | 0.74264042 |
| 55 | PIK3CG | 0.69060881 |
| 56 | MAPK11 | 0.67345503 |
| 57 | MET | 0.65950129 |
| 58 | CDK6 | 0.65780853 |
| 59 | MAP2K2 | 0.65724072 |
| 60 | RET | 0.64811428 |
| 61 | TGFBR2 | 0.64638032 |
| 62 | PTK2 | 0.62634351 |
| 63 | SCYL2 | 0.61772469 |
| 64 | PDPK1 | 0.61754431 |
| 65 | CSNK1D | 0.60652071 |
| 66 | PRKCB | 0.60506648 |
| 67 | MYLK | 0.60472333 |
| 68 | CAMKK1 | 0.59331963 |
| 69 | ZAP70 | 0.58529096 |
| 70 | BLK | 0.57427680 |
| 71 | RIPK1 | 0.56637856 |
| 72 | RPS6KA3 | 0.56068385 |
| 73 | STK16 | 0.55998998 |
| 74 | LATS1 | 0.51510047 |
| 75 | TESK2 | 0.50685707 |
| 76 | MAP3K3 | 0.50645805 |
| 77 | CSNK1A1 | 0.50420719 |
| 78 | JAK2 | 0.49518457 |
| 79 | SRC | 0.49367654 |
| 80 | PRKACB | 0.48774720 |
| 81 | EPHB2 | 0.47130352 |
| 82 | TYK2 | 0.47083737 |
| 83 | CDK4 | 0.46948952 |
| 84 | KDR | 0.46068671 |
| 85 | PRKACG | 0.45198595 |
| 86 | CAMK1D | 0.44651871 |
| 87 | PRKCZ | 0.44610140 |
| 88 | SGK1 | 0.44230944 |
| 89 | PAK4 | 0.43742543 |
| 90 | CAMK2G | 0.43074558 |
| 91 | PDK1 | 0.42730034 |
| 92 | DAPK2 | 0.41191258 |
| 93 | MAP3K2 | 0.40576114 |
| 94 | TAOK3 | 0.39906647 |
| 95 | FER | 0.39451618 |
| 96 | MAP2K4 | 0.38663552 |
| 97 | STK11 | 0.36771769 |
| 98 | MAP3K14 | 0.36687044 |
| 99 | CSNK1E | 0.36404256 |
| 100 | CSNK2A2 | 0.36169909 |
| 101 | PAK3 | 0.34778261 |
| 102 | CAMK1G | 0.34133083 |
| 103 | MAPKAPK3 | 0.33621216 |
| 104 | CSK | 0.33131503 |
| 105 | CSNK2A1 | 0.32634463 |
| 106 | PIM2 | 0.31609410 |
| 107 | IKBKE | 0.31559009 |
| 108 | MAPK3 | 0.30517162 |
| 109 | PRKCI | 0.28931911 |
| 110 | MAP2K1 | 0.27947424 |
| 111 | MTOR | 0.26993609 |
| 112 | ERBB4 | 0.25653223 |
| 113 | MAP2K3 | 0.25482404 |
| 114 | PRKCA | 0.24868788 |
| 115 | MAPK12 | 0.23335672 |
| 116 | KSR2 | 0.22493879 |
| 117 | PTK2B | 0.21380778 |
| 118 | PRKD2 | 0.21290697 |
| 119 | MAPK15 | 0.21061636 |
| 120 | PIK3CA | 0.20807002 |
| 121 | PRKCQ | 0.20788210 |
| 122 | PRKCD | 0.20574569 |
| 123 | ERBB2 | 0.19905891 |
| 124 | MAP3K11 | 0.19677045 |
| 125 | EPHA4 | 0.19350221 |
| 126 | TBK1 | 0.18639684 |
| 127 | TAOK1 | 0.17114802 |
| 128 | MAP2K6 | 0.16882074 |
| 129 | PRKACA | 0.15826551 |
| 130 | MAPK4 | 0.15807366 |
| 131 | STK10 | 0.15751702 |
| 132 | PRKG2 | 0.15121515 |
| 133 | AKT2 | 0.14669713 |
| 134 | LMTK2 | 0.13377442 |
| 135 | FLT3 | 0.12440801 |
| 136 | NEK9 | 0.11941791 |
| 137 | ICK | 0.11478997 |
| 138 | CAMKK2 | 0.10975311 |
| 139 | MAP3K13 | 0.10637611 |
| 140 | NTRK1 | 0.10272948 |
| 141 | PRKCH | 0.09443017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.71299062 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.33193922 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.21525498 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08739806 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.87681358 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.77964812 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.77788868 |
| 8 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73707840 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60129025 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.56319774 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54625698 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.47282012 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.41420013 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34228098 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28776504 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28058866 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25844363 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18317460 |
| 19 | * Peroxisome_Homo sapiens_hsa04146 | 2.13885951 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07642036 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97412247 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96325543 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.87926451 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85531874 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.77055957 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76683825 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76216535 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69135465 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68793356 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51546316 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48300005 |
| 32 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.46333503 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45506985 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41693162 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.31389340 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30699782 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27473926 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25511983 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25192604 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23090143 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22274691 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17732321 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16121252 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14550017 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12442758 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.11648607 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09476032 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99434048 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98235196 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97473901 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94626715 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90908278 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84118867 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76768491 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76074236 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.70360903 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70203884 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68594162 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68033972 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67964825 |
| 61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67242845 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.65648774 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63861192 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60688543 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59914671 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55210601 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54853518 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52221805 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52095569 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50207693 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49278914 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45294402 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43193265 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40669919 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38782147 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.35346040 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34218724 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32121964 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29226011 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28903136 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22240147 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22201501 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21851881 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20531868 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.19337619 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18917167 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18426002 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16998572 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.16889855 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14386476 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.10782191 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09285881 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02194676 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01804244 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01330229 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.00187493 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | -0.2755961 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2667159 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2487800 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2428291 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2387301 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2257082 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2113381 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1650705 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1180352 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0829992 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0702191 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0544260 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0469043 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0440959 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0329277 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0240745 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0052082 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | -0.0011847 |

